As per Roots Analysis, most of
the viral vector and gene therapy manufacturers (66%) are located in North
America, followed by the players headquartered in Europe (32%) and Asia-Pacific
(9%). Within North America, majority of the companies focused on manufacturing
viral vectors and gene therapies are based in the US (65). Further, in Europe,
most of the players are located in France (10), followed by those headquartered
in the UK (8) and Germany (6). In Asia-Pacific and RoW, maximum number of
companies (4) are based in Japan, followed by those companies located in China
(3) and Israel (2).
Additionally,
it was noticed that, North America is the current hub for the production of
viral vectors, featuring the presence of 53% of the total manufacturing
facilities. Within this region, most (81) of the facilities are located in the
US. This is followed by Europe, where approximately 37% of the total facilities
are located. In Europe, maximum number of facilities are based in France (12),
followed by those located in the UK (11) and Germany (9).
Multiple Players with Expertise in Manufacturing Vector and Gene Therapy have Emerged in this Domain in the Past Few Years
In
this analysis, we have compared more than 140 vector and gene therapy
manufacturers across multiple parameters. The insights on company competitiveness have been presented
in the form of four-dimensional bubble charts, with supplier power on the abscissa, manufacturing
strength on the ordinate. Further, size of the bubble is representative of
the service strength, while color indicates company size.
The purpose of this analysis was to compare the relative popularity and
activity of vector and gene therapy manufacturers. At no point, should the discussion in this chapter
be construed as a firm recommendation that one firm is better than the others.
Kindly note that, for the purpose of this analysis, information was collated
from various publicly available sources and company websites.
A detailed information on the key players, partnerships inked by the manufacturers,
company competitiveness, capacity analysis, demand
analysis and the likely market
evolution, was done by Roots Analysis in Q1 2021. For Further, information
visit this
